摘要
为了探讨参麦注射液对冠心病的治疗作用，我们以能量合剂为对照，用参麦注射液治疗了６０例冠心病患者。结果发现，参麦注射液治疗病人临床症状和心电图改善情况均明显优于使用能量合剂的病人。因此认为，参麦注射液对冠心病患者具有显著疗效，且用药安全，无明显副作用。
In order to evaluate the role of Shenmai injection in the treatment of coronary heart disease, 60 patients with coronary heart disease were treated with Shenmai injection or energetic compound separately.It was found that clinical manifestation and electrocardiogram changes in the patients treated with Shenmei injection were significantly improved,compared with the patients treated with energetic compound.The results suggested that Shenmai injection could improve the supply of blood for heart and was used safely.No side effect was seen.
出处
《药学进展》
CAS
1999年第1期44-46,共3页
Progress in Pharmaceutical Sciences
